These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 27081189)

  • 1. Cardiovascular risk, chronic obstructive pulmonary disease and pulmonary rehabilitation: Can we learn from cardiac rehabilitation?
    Triest FJ; Singh SJ; Vanfleteren LE
    Chron Respir Dis; 2016 Aug; 13(3):286-94. PubMed ID: 27081189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary comorbidities in cardiac rehabilitation.
    Bauldoff GS; Carlin BW
    Prog Cardiovasc Dis; 2022; 70():190-194. PubMed ID: 35151694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation.
    Noteboom B; Jenkins S; Maiorana A; Cecins N; Ng C; Hill K
    J Cardiopulm Rehabil Prev; 2014; 34(1):75-9. PubMed ID: 24326901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary rehabilitation and cardiovascular disease.
    Troosters T; Remoortel HV
    Semin Respir Crit Care Med; 2009 Dec; 30(6):675-83. PubMed ID: 19941225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity associated with referral to pulmonary rehabilitation in people hospitalized with chronic obstructive pulmonary disease.
    Li LS; Caughey G; Johnston K
    J Cardiopulm Rehabil Prev; 2014; 34(6):430-6. PubMed ID: 25166258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Rehabilitation Utilization in Older Adults With Chronic Obstructive Pulmonary Disease, 2003 to 2012.
    Nishi SP; Zhang W; Kuo YF; Sharma G
    J Cardiopulm Rehabil Prev; 2016; 36(5):375-82. PubMed ID: 27428819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordant Evidence-Based Interventions in Cardiac and Pulmonary Rehabilitation Guidelines.
    Smith SMS; Chaudhary K; Blackstock F
    J Cardiopulm Rehabil Prev; 2019 Jan; 39(1):9-18. PubMed ID: 30461546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics].
    Ambatiello LG; Chazova IE
    Ter Arkh; 2020 Apr; 92(3):78-83. PubMed ID: 32598797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Walking towards personalized medicine in pulmonary rehabilitation: Comorbidities and COPD.
    Evans RA
    Chron Respir Dis; 2016 Aug; 13(3):284-5. PubMed ID: 27488126
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular risk in chronic obstructive pulmonary disease.
    Maclay JD; McAllister DA; Macnee W
    Respirology; 2007 Sep; 12(5):634-41. PubMed ID: 17875049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of pulmonary rehabilitation in reducing health resources use in chronic obstructive pulmonary disease.
    Rubí M; Renom F; Ramis F; Medinas M; Centeno MJ; Górriz M; Crespí E; Martín B; Soriano JB
    Arch Phys Med Rehabil; 2010 Mar; 91(3):364-8. PubMed ID: 20298825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation in Pulmonary Rehabilitation by Veterans Health Administration and Medicare Beneficiaries After Hospitalization for Chronic Obstructive Pulmonary Disease.
    Vercammen-Grandjean C; Schopfer DW; Zhang N; Whooley MA
    J Cardiopulm Rehabil Prev; 2018 Nov; 38(6):406-410. PubMed ID: 30252780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.
    Sidney S; Sorel M; Quesenberry CP; DeLuise C; Lanes S; Eisner MD
    Chest; 2005 Oct; 128(4):2068-75. PubMed ID: 16236856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of comorbidities on outcomes of pulmonary rehabilitation programs in patients with COPD: a systematic review.
    Hornikx M; Van Remoortel H; Demeyer H; Marcal Camillo CA; Decramer M; Janssens W; Troosters T
    Biomed Res Int; 2013; 2013():146148. PubMed ID: 24490146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?
    Stone IS; Barnes NC; Petersen SE
    Heart; 2012 Jul; 98(14):1055-62. PubMed ID: 22739636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment.
    Wood-Baker R; Cochrane B; Naughton MT
    Intern Med J; 2010 Feb; 40(2):94-101. PubMed ID: 19849745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can a chronic disease management pulmonary rehabilitation program for COPD reduce acute rural hospital utilization?
    Rasekaba TM; Williams E; Hsu-Hage B
    Chron Respir Dis; 2009; 6(3):157-63. PubMed ID: 19643830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in rehabilitation for chronic diseases: improving health outcomes and function.
    Richardson CR; Franklin B; Moy ML; Jackson EA
    BMJ; 2019 Jun; 365():l2191. PubMed ID: 31208954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.